Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Bringing Medicines to Market Faster Through Analytics & Machine Learning

Traditional medicine isn’t generally taken very seriously in the United States. However, Dr. Andrea Small-Howard, President and CSO at GB Sciences explained that “65% of the world still use traditional medicine either as their sole medicine or in conjunction with Western medicine.” Depending on the source, traditional plant-based medicine dates back as far as…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from I Don't Care on MarketScale.

Share

Traditional medicine isn’t generally taken very seriously in the United States. However, Dr. Andrea Small-Howard, President and CSO at GB Sciences explained that “65% of the world still use traditional medicine either as their sole medicine or in conjunction with Western medicine.” Depending on the source, traditional plant-based medicine dates back as far as 60,000 years whereas Western medicine is a mere 3,000 years old.

Kevin Stevenson, I Don’t Care podcast host, sat down with the distinguished Dr. Small-Howard to discuss her work in the plant-based medicine industry. Dr. Small-Howard will also discuss the digital transformation curve with GB Sciences AI-based drug discovery platform PhAROS. This podcast is of great interest due in part to Dr. Small-Howard’s extensive resume. In fact, it is so extensive that the following introduction from her LinkedIn profile barely highlights her expertise.

“Dr. Andrea Small-Howard has 25 years of scientific research and executive experience in the biopharma industry supervising research & development, manufacturing, and quality control divisions in the US and China. Dr. Small-Howard has taken novel biological products from ideation through commercialization. She has been named an inventor on seventy+ patent applications, taken the lead in obtaining regulatory approvals from the U.S. Food and Drug Administration (‘US FDA’), and orchestrated commercial licensing deals.”

Listeners might think that they would not be able to understand or relate to such a well-educated scientific mind, but nothing could be further from the truth. Dr. Small-Howard is an engaging speaker filled with enthusiasm for her chosen line of work and her mission to normalize plant-based medicine in the United States.

“My background is in biochemistry, so I sort of see the world through a different lens and I’ve always been obsessed with the power of plant-based medicines. Traditional medicine is often overlooked as being a really powerful force here in the United States,” said Dr. Small-Howard. The doctor joined GB Sciences in 2014 to take plant-based medicine to the next level by utilizing science to maximize the potential of the cannabis plant.

More Like This Story:

Behavioral Health Is Stepping Out of the Shadows of Healthcare

Tearing Down the Barrier of Prior Authorization Through Automation

I Don't Care

Part of this channel

I Don't Care

Candid healthcare leadership conversations with Kevin Stevenson

Visit the channel →

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Clinical AI at a crossroads: skill decay, robotic surgery, and the wearable data frontier

Clinical AI at a crossroads: skill decay, robotic surgery, and the wearable data frontier

The article discusses the impact of three converging developments on the use of AI in healthcare: skill decay, robotic surgery, and wearable data analytics. These advancements are prompting health system operators to reevaluate the deployment and management of AI in clinical environments. The focus is on how AI is integrated, governed, and assessed in healthcare settings.

  • 01Health systems are rethinking AI deployment due to the impact of skill decay, robotic surgery, and wearable data.
  • 02The integration of AI in healthcare requires reevaluation of governance and evaluation processes.
  • 03Robotic surgery and wearable data are key areas influencing AI usage in clinical settings.

Jul 18, 2026

Healthcare CIOs are shifting from AI deployment to AI governance

Healthcare CIOs are shifting from AI deployment to AI governance

Healthcare executives are focusing more on the governance of AI technologies rather than just their deployment. Ensuring AI models remain accurate, accountable, and trusted is becoming the new challenge for technology leaders in health systems.

  • 01AI governance is becoming more crucial than just deployment in healthcare technology.
  • 02Maintaining accuracy and accountability in AI models is a primary concern for healthcare CIOs.
  • 03Trust in AI systems is essential for their successful integration into healthcare.

Jul 18, 2026

CMS launches dedicated health technology office as AI and interoperability pressure mounts on hospital IT teams

CMS launches dedicated health technology office as AI and interoperability pressure mounts on hospital IT teams

The Centers for Medicare & Medicaid Services (CMS) have established a new Office of Health Technology and Products. This office aims to integrate AI, promote interoperability, and advance digital health strategies, thereby increasing demands on hospital IT teams.

  • 01CMS has launched an Office of Health Technology and Products to focus on AI, interoperability, and digital health strategy.
  • 02The new CMS office will increase demands and expectations on hospital IT teams.
  • 03Improving interoperability and integrating AI in healthcare is a crucial priority for CMS.

Jul 18, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512